Estrogen Receptors and HER2 Levels ' Expression in Luminal Metastatic Breast Cancer: Correlation to Therapeutic Efficacy of Cycline-Dependent Kinase Inhibitors(CDK4/6) as First Line Treatment. CYCLHER Study
Conditions: Advanced Breast Carcinoma Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | HER2 | Research | Study